Trial intelligence / Profile preview

Aixite medicinal charcoal tablets for prevention of acute gout flares during urate-lowering therapy

ChiCTR2200066023Phase 4Not yet recruiting

Sponsor
The Affiliated Hospital of Qingdao University
Start
Nov 2022
Modality
Small Molecules
Countries
1
01

Overview

Phase 4 trial of activated charcoal in gout (3 arms), sponsored by The Affiliated Hospital of Qingdao University. Primary endpoints: Acute gout flares and Serum uric acid (SU). Planned start Nov 2022; status: not yet recruiting.

02

Drugs

activated charcoal
03

Conditions

gout

Beyond the preview

Go deeper on ChiCTR2200066023.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2200066023.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call